| Pipeline | Target Indication | Discovery | Pre-clinical | Phase1 | Phase2 | Phase3 |
|---|---|---|---|---|---|---|
| SCB001 | CRC | |||||
| SCB002 | Pancreatic Cancer | |||||
| SCB003 | Disclosed | |||||
| SCB004 | Disclosed | |||||
| SCB005 | Advanced Solid Cancer | |||||
| SCB006 | Advanced Solid Cancer | |||||
| SCB007 | Disclosed | |||||
| SCB008 | IPF | |||||
| SCB010 | Hypertrophic cardiomyopathy & Atherosclerosis |
|||||
| SCB011 | Disclosed |
TEL +82-42-381-1237 │ FAX +82-42-381-1233 │ Email info@sc-bio.co.kr │ ADMIN
94-14 Techno 2-ro, Yuseong-gu, Daejeon, 34014, Korea │ Copyright ⓒ 2022 SCBIO All Rights Reserved.
TEL +82-42-381-1237 │ FAX +82-42-381-1233
Email info@sc-bio.co.kr │ ADMIN
94-14 Techno 2-ro, Yuseong-gu, Daejeon, 34014, Korea
Copyright ⓒ 2022 SCBIO All Rights Reserved.